Mechanistic evidence revealed that lnc-EGFR specially bound to EGFR and enhanced AP-1/NF-AT1/Foxp3 signaling, leading to Treg differentiation, and HCC progression (68). This evidence concerns the gene FOXP3 and hepatocellular carcinoma.